# Cathay Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cathay-biotech

- Industry: Chemicals
- Headquarters: Shanghai, China
- Website: www.cathaybiotech.com
- Total disclosed funding: $223M
- Latest round: Series B (Jun 14, 2019)
- Investors on record: 8

## About

Established in 1997 and based in Shanghai, China, Cathay Industrial Biotech Ltd. operates as a biotechnology company that focuses on developing chemicals used for nylons, polyesters and adhesives and bio-solvents.

## Funding rounds

- Series B, Jun 14, 2019, $10M — HBM Partners
- Series C, Oct 1, 2007, $135M — New Enterprise Associates, Morgan Stanley Private Equity Asia, NLVC, New Horizon Capital, BVCF Capital
- Series B, Dec 4, 2006, $52M — HBM Partners, Shanghai Pudong Hi-tech Investment, New Horizon Capital, BVCF Capital, Goldman Sachs Asset Management
- Series A, Sep 11, 2006, $26M — HBM Partners, Shanghai Pudong Hi-tech Investment, New Horizon Capital, BVCF Capital

## Investors

- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series A, Series B
- Shanghai Pudong Hi-tech Investment (https://capitalatlas.ai/funds/shanghai-pudong-hi-tech-investment) — Series A, Series B
- New Horizon Capital — Series A, Series B, Series C
- BVCF Capital — Series A, Series B, Series C
- Goldman Sachs Asset Management (https://capitalatlas.ai/funds/goldman-sachs-asset-management) — Series B
- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series C
- Morgan Stanley Private Equity Asia (https://capitalatlas.ai/funds/morgan-stanley-private-equity-asia) — Series C
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series C